Clinical Trial

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

Study acronym: FILOSOPHY
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
An observational study to describe the effectiveness, safety, and patient-reported outcomes in patients with moderate to severe active rheumatoid arthritis (RA) receiving filgotinib in real-world setting.
Protocol Amendment History 27 amendments
This ClinicalTrials.gov record has been amended 27 times since 2021-04-29; most recent amendment 2025-09-09.
Status change: Recruiting → Active, Not Recruiting 2024-05-14
Status change: Not Yet Recruiting → Recruiting 2021-05-19
Trial Details
NCT Number NCT04871919
Lead Sponsor Alfasigma S.p.A.
Conditions Rheumatoid Arthritis
Enrollment 1,304 participants
Start Date 2021-05-11
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-15